For: | Katoch S, Sharma V, Patial V. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios. World J Gastroenterol 2022; 28(28): 3535-3554 [PMID: 36161051 DOI: 10.3748/wjg.v28.i28.3535] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i28/3535.htm |
Number | Citing Articles |
1 |
Zhenshan Zhang, Leilei Wu, Juan Li, Jiayan Chen, Qi Yu, Hui Yao, Yaping Xu, Liang Liu. Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03790-0
|
2 |
Vinesh Sharma, Vikram Patial. Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.991059
|
3 |
Ephraim E Parent, Amy M Fowler. Nuclear Receptor Imaging In Vivo—Clinical and Research Advances. Journal of the Endocrine Society 2023; 7(3) doi: 10.1210/jendso/bvac197
|